Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

Exclusion Criteria

• •Impaired renal function (plasma creatinine ≥150 µmol/L or glomerular filtration rate as estimated by the Cockcroft-Gault formula ≤50ml/min)
• •Cardiac problems (unstable angina or myocardial infarction within the previous 12 months or New York Heart Association class III or IV congestive heart failure
• •Mentally handicapped
• •Current or past psychiatric treatment for schizophrenia
• •Cognitive or bipolar disorder
• •Current use or oral corticosteroids or suffering from a condition which necessitated oral or systemic corticosteroids use more than once in the previous 12 months
• •Substance abuse, other than nicotine
• •Current gravidity or plans to become pregnant during the trial
• •Plans to engage in activities that require going \>25 feet below sea level
• •Any condition that the investigator and/or coordinating investigator feels would interfere with trial participation or evaluation of results.
• •Impaired renal function (plasma creatinine ≥150 µmol/L or glomerular filtration rate as estimated by the Cockcroft-Gault formula ≤50ml/min)
• •Cardiac problems (unstable angina or myocardial infarction within the previous 12 months or New York Heart Association class III or IV congestive heart failure
• •Mentally handicapped
• •Current or past psychiatric treatment for schizophrenia
• •Cognitive or bipolar disorder
• •Current use or oral corticosteroids or suffering from a condition which necessitated oral or systemic corticosteroids use more than once in the previous 12 months
• •Substance abuse, other than nicotine
• •Current gravidity or plans to become pregnant during the trial
• •Plans to engage in activities that require going \>25 feet below sea level
• •Any condition that the investigator and/or coordinating investigator feels would interfere with trial participation or evaluation of results.